2 Stocks That Are Poised for Huge Increases This Year

Motley Fool readers with investment appetites in Q3 2021 have two great options. WELL Health Technologies stock and Kinaxis stock are poised to increase this year and deliver superior returns.

| More on:
Arrowings ascending on a chalkboard

Image source: Getty Images.

Investors in search of superior, if not extraordinary returns should consider growth stocks WELL Health Technologies (TSX:WELL) and Kinaxis (TSX:KXS). Market analysts recommend a strong buy rating for both. Their respective businesses should prosper in the economic recovery phase. Thus, the two stocks are well positioned for considerable increases in 2021.

Digital health modernization

WELL targets to modernize Canada’s under-digitized primary healthcare system. Since operational challenges are ever increasing, especially in the pandemic environment, the need is pressing.

This $1.49 billion company from Vancouver doubles as a primary healthcare operator and technology innovator. Management’s goal is to combine professional healthcare expertise with technology to empower physicians and patients better. It should result in improved experiences and health outcomes.

On July 15, 2021, WELL became the country’s largest outpatient medical clinic owner-operator. Its acquisition of MyHealth Partners Inc. made it the leading multi-disciplinary telehealth service provider. MyHealth is a leading primary care, specialty care, telehealth services, and accredited diagnostic health services provider.

The foundational acquisition was worth $206 million. WELL’s chairman and CEO Hamed Shahbazi said the acquisition offers financial shareholder value and supports its value system. In the first half of 2021, WELL made eight strategic acquisitions, including a comprehensive omnichannel practice management platform and a start-up fertility clinic.

The Q1 2021 (quarter ended March 31, 2021) results lend credence to the bullish sentiment on the healthcare stock. WELL reported record revenue during the quarter — 150% year-over-year growth. At the current share price of $7.30, the trailing one-year price return is 96.24% Analysts forecast a 61% return potential to $11.77 in the next 12 months.

Great value stock

Kinaxis trades at a discount (-8.38% year to date) following an 80% total return in 2020. Analysts’ price targets in the next 12 months are $195.39 (average) and $228.50 (maximum). The current share price is $165.22.

This $4.49 billion company from Ottawa provides cloud-based subscription software for supply chain operations that are local and international. Its lead cloud-based Software-as-a-Service (Saas) platform is RapidResponse. Clients such as Proctor & Gamble, Ford, and Honeywell take control of their integrated business planning and digital supply chain by using the said SaaS platform.

While revenue in Q1 2021 (quarter ended March 31, 2021) rose 9% versus Q1 202, Kinaxis reported a net loss of US$1.5 million. In the same period last year, the company posted US$5.58 million in net income. Still, its president and CEO, John Sicard, was pleased with the first-quarter results.

Management continues to experience COVID-related delays, although Sicard said the environment for booking new business had shown continued signs of improvement. Kinaxis hopes typical business and market conditions return soon. It can achieve between 23% and 25% in annual SaaS revenue growth in the mid-term. From 2021 to 2023 and later, Kinaxis has a total backlog of US$384 million. These are the revenues it expects to recognize in the future.

Vital services

WELL Health Technologies and Kinaxis should attract growth investors, given their potential astronomical returns. Modernization of the healthcare system and uninterrupted supply chain operations are the vital services they bring to the table. Expect the businesses to show further improvement, as Canada puts the emergency crisis behind it. The stocks’ breakouts should follow to prove analysts’ predictions accurate.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends KINAXIS INC.

More on Tech Stocks

consider the options
Tech Stocks

Is it Too Late to Buy Shopify Stock?

Shopify is one of the most popular stocks on the market. Is it too late to buy shares?

Read more »

Tech Stocks

2 Best Canadian Stocks Under $10 to Buy Now

Cheap TSX stocks such as Payfare and StorageVault are trading under $10. Both these stocks have significant upside potential in…

Read more »

edit Businessman using calculator next to laptop
Tech Stocks

Better Buy: BlackBerry Stock vs. CrowdStrike

BlackBerry and CrowdStrike are tech stocks part of the cybersecurity segment. Which is a better buy between CRWD stock and…

Read more »

A shopper makes purchases from an online store.
Tech Stocks

Better Buy: Shopify Stock or Amazon?

Shopify Inc. (TSX:SHOP) is well positioned for growth ahead.

Read more »

Piggy bank next to a financial report
Tech Stocks

TFSA Contribution in 2023: Where to Invest $6,500 Right Now

Here's why you need to consider buying NBLY stock and Docebo stock for your TFSA portfolio in 2023.

Read more »

A bull outlined against a field
Tech Stocks

3 Cheap Stocks I’d Buy in Bulk Before a Bull Market Arrives

After a hot start to the year, here are three discounted TSX stocks that I’d seriously consider loading up on…

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Better Buy: Shopify vs. Constellation Software

Are you interested in buying a tech stock? Find out which is the better buy between Shopify and Constellation Software.

Read more »

Woman has an idea
Tech Stocks

3 No-Brainer Stocks to Buy for Less Than the Cost of 1 Tesla Share

Are you confused as to whether to buy Tesla shares? Here are three no-brainer stocks that can give you exposure…

Read more »